Harvest Health (OTC: HRVSF)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-09 | ||||||
REV |
Q4 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-05-31 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Harvest Health (OTC: HRVSF) through any online brokerage.
There are no as such competitors for Harvest Health.
The latest price target for Harvest Health (OTC: HRVSF) was reported by Cantor Fitzgerald on Monday, January 25, 2021. The analyst firm set a price target for 3.70 expecting HRVSF to rise to within 12 months (a possible 14.91% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Harvest Health (OTC: HRVSF) is $3.22 last updated October 4, 2021, 7:59 PM UTC.
There are no upcoming dividends for Harvest Health.
Harvest Health’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Harvest Health.
Harvest Health is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTC.